Rapidly progressive skin / soft tissue infections
[Clin Infect Dis 2014;59:e10-52]
Predisposing factors
trauma/surgery
immunosuppression/malignancy
diabetes
chronic renal/hepatic disease
chicken pox
IVDU
Early:
pain out of proportion to appearance
edema or tenderness beyond the cutaneous erythema
cellulitis
fever
tachycardia
induration (hard, wooden feel of subcutaneous tissue)
areas of anaesthesia in affected skin
Late:
severe pain
skin discoloration/necrosis (purple or black)
blistering
hemorrhagic bullae
crepitus
"dishwater" gray drainage
systemic inflammatory response syndrome (SIRS)/sepsis
multi-organ failure/shock
- Surgical debridement and irrigation are essential. Send specimens for culture. For culture-directed therapy, see Culture-Directed Infections: Skin & Soft Tissue.
- Infectious Diseases consult strongly recommended.
- Duration of therapy (IV/PO) dependent on clinical picture.
Rapidly progressive skin/soft tissue infections
- On initial presentation it may be difficult to determine etiologic agent(s).
S. pyogenes (Group A Strep)
Mixed aerobic/anaerobic organisms
S. agalactiae (Group B Strep)
Group C,G Streptococci
S. pneumoniae
S. aureus/MRSA
Clostridium spp
Vibrio vulnificus (salt water exposure)
Aeromonas hydrophila (fresh water exposure)
Enterobacterales (chronic hepatic/renal disease)
P. aeruginosa (neutropenia, burns, IVDU)
Empiric Therapy | Dose | Duration |
---|---|---|
Ceftriaxone | 100mg/kg IV q24h | minimum 10 days |
+ | ||
Clindamycin | 40mg/kg/d IV div q8h |
Polymicrobial or MRSA suspected
Empiric Therapy | Dose | Duration |
---|---|---|
Piperacillin-tazobactam | 300mg piperacillin/kg/d IV div q6-8h | minimum 10 days |
+ | ||
[Vancomycin | 60mg/kg/d IV div q6h | |
or | ||
Linezolid] | < 5 y.o.: 30mg/kg/d IV/PO div q8h | |
> 5 y.o.: 20mg/kg/d IV/PO div q12h |